Literature DB >> 1710287

Molecular location of a species-specific epitope on the hamster scrapie agent protein.

D C Bolton1, S J Seligman, G Bablanian, D Windsor, L J Scala, K S Kim, C M Chen, R J Kascsak, P E Bendheim.   

Abstract

Scrapie is a transmissible neurodegenerative disease of sheep and goats. An abnormal host protein, Sp33-37, is the major protein component of the scrapie agent and the only known disease- or agent-specific macromolecule. Two monoclonal antibodies (MAbs), 4H8 (immunoglobulin G2b [IgG2b]) and 6B11 (IgG1), produced by immunizing mice with the intact hamster 263K scrapie agent protein, Sp33-37Ha, were found to have species specificity similar to that reported previously for MAb 3F4 (IgG2a), which was produced by using PrP-27-30 as the immunogen (R. J. Kascsak, R. Rubenstein, P. A. Merz, M. Tonna-DeMasi, R. Fersko, R. I. Carp, H. M. Wisniewski, and H. Diringer, J. Virol. 61:3688-3693, 1987). These antibodies all bound to Sp33-37 derived from hamster but not from mouse cells. Competitive binding assays demonstrated that all three MAbs bound to the same or overlapping sites on Sp33-37Ha. The molecular location of the epitope for these antibodies was determined to within 10 residues by using an antigen competition enzyme-linked immunosorbent assay in which synthetic peptides spanning Sp33-37Ha residues 79 to 93 or 84 to 93 specifically inhibited binding of these antibodies to plates coated with purified Sp33-37Ha. A synthetic peptide with the mouse-specific sequence (83 to 92) that differed from the hamster sequence by substitution at two positions (MetHa-87----LeuMo-86 and MetHa-90----ValMo-89) did not inhibit antibody binding to Sp33-37Ha. MAb 3F4 binding to hamster Sp33-37 was eliminated by chemical modification of Sp33-37Ha with diethylpyrocarbonate or succinic anhydride and by cleavage with CNBr or trypsin. The effect of diethylpyrocarbonate on MAb 3F4 binding was not reversed by hydroxylamine treatment. MAb 3F4 binding was not affected by prolonged exposure of Sp33-37Ha to 70% formic acid or by boiling in sodium dodecyl sulfate. We conclude that the epitope for these MAbs is a linear determinant that includes Met-87, Lys-88, and Met-90 and that Met-90 is probably the major species-specific determinant.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710287      PMCID: PMC241380     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains.

Authors:  R J Kascsak; R Rubenstein; P A Merz; R I Carp; N K Robakis; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

2.  Separation and properties of cellular and scrapie prion proteins.

Authors:  R K Meyer; M P McKinley; K A Bowman; M B Braunfeld; R A Barry; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  Immunoaffinity purification and neutralization of scrapie prion infectivity.

Authors:  R Gabizon; M P McKinley; D Groth; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  Isolation and structural studies of the intact scrapie agent protein.

Authors:  D C Bolton; P E Bendheim; A D Marmorstein; A Potempska
Journal:  Arch Biochem Biophys       Date:  1987-11-01       Impact factor: 4.013

5.  A cellular gene encodes scrapie PrP 27-30 protein.

Authors:  B Oesch; D Westaway; M Wälchli; M P McKinley; S B Kent; R Aebersold; R A Barry; P Tempst; D B Teplow; L E Hood
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

6.  Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene.

Authors:  K Basler; B Oesch; M Scott; D Westaway; M Wälchli; D F Groth; M P McKinley; S B Prusiner; C Weissmann
Journal:  Cell       Date:  1986-08-01       Impact factor: 41.582

7.  Transmission to animals of Creutzfeldt-Jakob disease from human blood.

Authors:  E E Manuelidis; J H Kim; J R Mericangas; L Manuelidis
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

8.  Purified prion proteins and scrapie infectivity copartition into liposomes.

Authors:  R Gabizon; M P McKinley; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

9.  Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein.

Authors:  N Stahl; M A Baldwin; A L Burlingame; S B Prusiner
Journal:  Biochemistry       Date:  1990-09-25       Impact factor: 3.162

10.  Acetylcholine receptor-inducing factor from chicken brain increases the level of mRNA encoding the receptor alpha subunit.

Authors:  D A Harris; D L Falls; R M Dill-Devor; G D Fischbach
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

View more
  39 in total

1.  Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.

Authors:  M Horiuchi; B Caughey
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum.

Authors:  R S Stewart; B Drisaldi; D A Harris
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

3.  Glycosylation influences cross-species formation of protease-resistant prion protein.

Authors:  S A Priola; V A Lawson
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

4.  Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155.

Authors:  S A Priola; J Chabry; K Chan
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Acute cellular uptake of abnormal prion protein is cell type and scrapie-strain independent.

Authors:  Christopher S Greil; Ina M Vorberg; Anne E Ward; Kimberly D Meade-White; David A Harris; Suzette A Priola
Journal:  Virology       Date:  2008-08-08       Impact factor: 3.616

6.  An N-terminal polybasic domain and cell surface localization are required for mutant prion protein toxicity.

Authors:  Isaac H Solomon; Natasha Khatri; Emiliano Biasini; Tania Massignan; James E Huettner; David A Harris
Journal:  J Biol Chem       Date:  2011-03-08       Impact factor: 5.157

7.  The extracellular regulated kinase-1 (ERK1) controls regulated alpha-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein.

Authors:  Moustapha Cissé; Eric Duplan; Marie-Victoire Guillot-Sestier; Joaquim Rumigny; Charlotte Bauer; Gilles Pagès; Hans-Dieter Orzechowski; Barbara E Slack; Frédéric Checler; Bruno Vincent
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

8.  An antibody raised against a conserved sequence of the prion protein recognizes pathological isoforms in human and animal prion diseases, including Creutzfeldt-Jakob disease and bovine spongiform encephalopathy.

Authors:  P Piccardo; J P Langeveld; A F Hill; S R Dlouhy; K Young; G Giaccone; G Rossi; M Bugiani; O Bugiani; R H Meloen; J Collinge; F Tagliavini; B Ghetti
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

9.  Detection of species specific epitopes of mouse and hamster prion proteins (PrPs) by anti-peptide antibodies.

Authors:  T Yokoyama; S Itohara; N Yuasa
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

10.  Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform.

Authors:  S Lehmann; D A Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.